Welcome: Wuhan Acome Biotechnology Co., Ltd.
info@acomebio.com +8615807175144

Tamoxifen | Nolvadex

Tamoxifen Citrate, Tamoxifen, Nolvadex powder
Contact: info@acomebio.com, Wickr Me: acomebio
CAS No: 54965-24-1
Molecular Formula: C32H37NO8
Molecular Weight: 563.64g/mol
Purity: >99%
Appearance: White to off-white
Transport Package: Aluminum Foil Bag or as Required


Basic Information about Nolvadex Tamoxifen Citrate
Tamoxifen (Nolvadex) is one of the most popular and essential drugs in the world. Tamoxifen (Nolvadex) belongs to a class of drugs called SERM's (Selective estrogen receptor modulators), so Tamoxifen (Nolvadex) is often considered to be an anti-estrogen. All in all, Tamoxifen (Nolvadex) can be considered both an estrogen agonist, and antagonist, since it binds to the estrogen receptors instead of estrogen, which we will discuss below. Thanks to an affordable price, Tamoxifen (Nolvadex) is popularly used during and after steroid cycles to help with estrogen.
Tamoxifen Citrate (Nolvadex) has been used medically for decades and has been highly successful in breast cancer treatment, specifically hormone-responsive breast cancer. Tamoxifen (Nolvadex) is also a medication that is used by many anabolic steroid users, but Tamoxifen (Nolvadex) is not a steroid. This is a drug steroid users will sometimes use during steroid use to help with estrogenic related side effects brought on by specific Steroids.


Uses of Nolvadex Tamoxifen Citrate
Tamoxifen Citrate (Nolvadex) is currently used for the treatment of both early and advanced estrogen receptor (ER)-positive (ER+) breast cancer in pre- and post-menopausal women. Additionally, Tamoxifen Citrate (Nolvadex) is the most common hormone treatment for male breast cancer. Tamoxifen Citrate (Nolvadex) is also approved by the FDA for the prevention of breast cancer in women at high risk of developing the disease. Tamoxifen Citrate (Nolvadex) has been further approved for the reduction of contralateral (in the opposite breast) cancer. The use of tamoxifen is recommended for 10 years.
In 2006, the large STAR clinical study concluded that raloxifene is equally effective in reducing the incidence of breast cancer, but after an average 4-year follow-up there were 36% fewer uterine cancers and 29% fewer blood clots in women taking raloxifene than in women taking Tamoxifen Citrate (Nolvadex), although the difference was not statistically significant.


Nolvadex Tamoxifen Citrate Use Instructions
Before taking tamoxifen, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
If you have cancer limited to the milk ducts, or if you are taking this medication to prevent breast cancer, then this medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: a history of blood clots (e.g., deep vein thrombosis, pulmonary embolism, stroke), conditions that require treatment with a "blood thinner" (such as warfarin).